John Coombs

1.7k citations
45 papers · 1.4k · 1 hit paper · h-index 17

Impact in

    • Medication Adherence and Compliance
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments

Papers in

    • Chronic Myeloid Leukemia Treatments 14
    • Chronic Lymphocytic Leukemia Research 10

John Coombs

45 papers receiving 1.3k citations

John Coombs's Hit Papers

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo 2009 · 453 citations
4530+5+11Years since publication100200300400

Peers

John Coombs
Comparison fields: 5 of 97
  • Family Practice 112
  • Rheumatology 450
  • Hematology 275
  • Genetics 182
  • Gastroenterology 75
Replace Tamás Koncz with:
Tamás Koncz United States
Weiwei Feng China
Arijit Ganguli United States
Ivy Altomare United States
Sarika Ogale United States
Anders Själander Sweden
Avi Leader Israel
Aart Beeker Netherlands
Serge Benayoun Canada
J P Droz France
John Coombs relative to Tamás Koncz United States Tamás Koncz's profile →
Citations per field
00.5×7.5×
Tamás Koncz · 1×
Citations per year

Countries citing papers authored by John Coombs

Since Specialization
Citations

This map shows the geographic impact of John Coombs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Coombs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Coombs more than expected).

Fields of papers citing papers by John Coombs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Coombs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Coombs. The network helps show where John Coombs may publish in the future.

Co-authors

The 25 scholars most cited alongside John Coombs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Coombs Line = papers co-authored together John Coombs links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo
Hit paper breakdown →
2009453
2 2009117
3 2009113
4 200188
5 200567
6 200659
7
Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.
200657
8 201249
9 200641
10 201139
11 200936
12 200534
13
Preliminary development of a responder index for chronic low back pain.
200731
14 201219
15 201218
16 201117
17 201316
18 201013
19
Compliance and refill pattern behavior with HMG-CoA reductase inhibitors after acute myocardial infarction.
200213
20 200912

About John Coombs

John Coombs is a scholar working on Hematology, Genetics, Gastroenterology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (10 papers), Gastrointestinal Tumor Research and Treatment (8 papers), Acute Lymphoblastic Leukemia research (6 papers), Cancer survivorship and care (3 papers), Click Chemistry and Applications (2 papers), Spondyloarthritis Studies and Treatments (2 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Family Practice (112 citations), Rheumatology (450 citations), Hematology (275 citations), Genetics (182 citations) and Gastroenterology (75 citations). John Coombs has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Samuel H. Zwillich, Bradley J. Bloom, David Gruben, Joel M. Kremer, Cristiano A. F. Zerbini, Bethanie Wilkinson, Mark P. Fletcher, Rubén Burgos‐Vargas, Ferdinand C. Breedveld and Sriram Krishnaswami. Their work appears in journals such as Blood, Journal of Clinical Oncology, Value in Health, Quality of Life Research and Annals of Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact